2633 Jacobson Pharma Corporation Limited HKEX · Hong Kong

Jacobson Pharma Corporation (2633) news

Jacobson Pharma Corporation Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2633, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Jacobson Pharma Corporation news

We have not published a story on Jacobson Pharma Corporation yet. When there is news, it will appear here.

Questions about Jacobson Pharma Corporation

What is the ticker symbol of Jacobson Pharma Corporation?

Jacobson Pharma Corporation Limited trades under the ticker 2633 on HKEX.

Where is Jacobson Pharma Corporation listed?

Jacobson Pharma Corporation Limited is listed on HKEX.

Which country or territory is Jacobson Pharma Corporation listed under?

Our directory records Jacobson Pharma Corporation Limited under Hong Kong.

What does Jacobson Pharma Corporation do?

Our directory classifies Jacobson Pharma Corporation Limited as: Pharmaceuticals: Generic. This is a directory classification, not a description of the pipeline.

What is the ISIN of Jacobson Pharma Corporation?

The ISIN recorded for Jacobson Pharma Corporation Limited is KYG677291067.

Does aibio.space cover Jacobson Pharma Corporation?

aibio.space lists Jacobson Pharma Corporation Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Jacobson Pharma Corporation?

Companies in our directory listed in the same country and business area as Jacobson Pharma Corporation: JBM (Healthcare), Wai Yuen Tong Medicine Holdings, Tianda Pharmaceuticals, Grand Pharmaceutical Group, Sanai Health Industry Group Company, Sirnaomics.

Investor discussion: Jacobson Pharma Corporation

Members talk about Jacobson Pharma Corporation (2633). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Jacobson Pharma Corporation, newest first. Each line links the filing it comes from.

Jul 16, 2026Financings
Share or debt issue: PROPOSED RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN NINE YEARS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING. Source
Apr 1, 2026Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION ACCEPTANCE OF TENDER IN RELATION TO THE PROVISION OF SPECIAL INFRASTRUCTURE DEVELOPMENT AND SPECIALISED FACILITIES WORKS AT TAI PO INNOPARK. Source
Jul 3, 2025Financings
Share or debt issue: PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND NOTICE OF ANNUAL GENERAL MEETING. Source
May 16, 2025Mergers
Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION SUBSCRIPTION OF SHARES IN TYCOON GROUP HOLDINGS LIMITED. Source
Apr 29, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION SUBSCRIPTION OF SHARES IN TYCOON GROUP HOLDINGS LIMITED. Source

Press releases

Headlines of Jacobson Pharma Corporation's own announcements, newest first. Each opens the full release on the newswire that carried it.

Aug 11, 2026HKEXnews
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, 11 AUGUST 2026; (2) PAYMENT OF FINAL DIVIDEND; AND (3) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEES
Jul 16, 2026HKEXnews
Notification Letter and Request Form to Non-registered Shareholders
Jul 16, 2026HKEXnews
Notification Letter and Reply Form to Registered Shareholders
Jul 16, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Jul 16, 2026HKEXnews
PROPOSED RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN NINE YEARS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING
Jun 29, 2026HKEXnews
JOINT ANNOUNCEMENT CONNECTED TRANSACTION IN RELATION TO SALE AND PURCHASE OF SHARES IN LI CHUNG SHING TONG (HOLDINGS) LIMITED
Jun 23, 2026HKEXnews
Final Dividend for the Year Ended 31 March 2026
Jun 23, 2026HKEXnews
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2026
Jun 23, 2026HKEXnews
RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Apr 1, 2026HKEXnews
DISCLOSEABLE TRANSACTION ACCEPTANCE OF TENDER IN RELATION TO THE PROVISION OF SPECIAL INFRASTRUCTURE DEVELOPMENT AND SPECIALISED FACILITIES WORKS AT TAI PO INNOPARK
Mar 6, 2026HKEXnews
JOINT ANNOUNCEMENT RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
Nov 18, 2025HKEXnews
Interim Dividend for the Six Months Ended 30 September 2025
Nov 18, 2025HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Oct 28, 2025HKEXnews
JOINT ANNOUNCEMENT CONNECTED TRANSACTION AND CONTINUING CONNECTED TRANSACTION 2025 EUROPHARM LICENSE AGREEMENT
Jul 28, 2025HKEXnews
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MONDAY, 28 JULY 2025; (2) PAYMENT OF FINAL DIVIDEND AND SPECIAL DIVIDEND; AND (3) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEES
Jul 28, 2025HKEXnews
Terms of Reference for Nomination Committee
Jul 11, 2025HKEXnews
RECORD DATE FOR ANNUAL GENERAL MEETING AND PROPOSED FINAL DIVIDEND AND SPECIAL DIVIDEND
Jul 3, 2025HKEXnews
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Jun 13, 2025HKEXnews
Special Dividend for the Year Ended 31 March 2025
Jun 13, 2025HKEXnews
Final Dividend for the Year Ended 31 March 2025

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2633 on TradingView.

Listing details

Company: Jacobson Pharma Corporation Limited
Ticker: 2633
Listing: HKEX
Country or territory: Hong Kong
Business scope: Pharmaceuticals: Generic
ISIN: KYG677291067
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction